Antibody signatures in inflammatory bowel disease: current developments and future applications

Area of Science:

• Gastroenterology and Immunology
• Molecular Biology and Genetics

Background:

• The intestinal barrier prevents pathogen entry while tolerating beneficial microbes and self-antigens.
• Inflammatory bowel diseases (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), are linked to intestinal barrier dysfunction.
• This dysfunction allows excessive luminal antigen passage, triggering inappropriate immune responses.

Purpose of the Study:

• To review current knowledge of antigens implicated in IBD.
• To highlight novel high-throughput antibody profiling technologies for characterizing humoral immunity in IBD.
• To discuss the potential applications of these technologies in IBD diagnostics, treatment, and prevention.

Main Methods:

• Review of established serological antibodies.
• Application of novel high-throughput methods: protein arrays, phage-display immunoprecipitation sequencing (PhIP-Seq), and B cell receptor sequencing (BCRseq).

Main Results:

• Innovative antibody profiling technologies enable systematic characterization of humoral immunity.
• These methods facilitate the identification of specific antigens associated with IBD.
• Understanding these antigens is crucial for advancing IBD research.

Conclusions:

• Advanced antibody profiling techniques are revolutionizing the study of IBD.
• These technologies hold significant promise for developing targeted diagnostics and therapeutics for IBD.
• Future applications may include personalized medicine and preventative strategies for IBD.